Mycotopia Therapies (Mycotopia Therapies) Stock Based Compensation : $0.04 Mil (TTM As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Mycotopia Therapies Stock Based Compensation?

Mycotopia Therapies's Stock Based Compensation for the three months ended in Dec. 2023 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was $0.04 Mil.

Mycotopia Therapies Stock Based Compensation Historical Data

The historical data trend for Mycotopia Therapies's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mycotopia Therapies Stock Based Compensation Chart

Mycotopia Therapies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Stock Based Compensation

Get a 7-Day Free Trial

4.31

1.02

Mycotopia Therapies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Stock Based Compensation	Get a 7-Day Free Trial															-	-	0.04	-	-

Mycotopia Therapies Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.04 Mil.

Mycotopia Therapies Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Mycotopia Therapies's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mycotopia Therapies (Mycotopia Therapies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mycotopia Therapies Inc (OTCPK:TPIA) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

18851 NE 29th Avenue, Suite 700, Aventura, FL, USA, 33180

Website

https://www.mycotopiatherapies.com

Mycotopia Therapies Inc provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions.

Executives

Mark D. Williams	director, 10 percent owner, officer: President, CEO & CFO	480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin	director, 10 percent owner, officer: Vice President	480 22ND STREET, BOX 2, HEYBURN ID 83336